Back

Crucell N.V.

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 09 mar 2006 - 08:03
  • Statutory name Crucell N.V.
  • Title Crucell and DSM Biologics Announce PER.C6® Licensing Agreement with UMN Pharma
  • Comments Dutch biotechnology company Crucell N.V. (Euronext and NASDAQ: CRXL; Swiss Exchange: SW CRX) and allied contract manufacturer DSM Biologics announced today that they have signed a PER.C6® research license agreement with Japanese pharmaceutical company UMN Pharma.

Related downloads

200603090000000017_UMN_NL_FINAL_09Mar06.pdf
200603090000000017_UMN_UK_FINAL_09Mar06.pdf

Date last update: 12 August 2020

Share information

Share on: Share this